Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021
David García-García(Instituto de Salud Carlos III), Diana Gómez‐Barroso(Instituto de Salud Carlos III), Ayelén Rojas‐Benedicto(Universidad Nacional de Educación a Distancia), Inmaculada León-Gómez(Instituto de Salud Carlos III), Herranz-Hernandez Rafael(Hospital Clínico San Carlos), Amparo Larrauri(Instituto de Salud Carlos III), Rebeca Ramis, María Guerrero-Vadillo(Instituto de Salud Carlos III), Marina Peñuelas
Cited by 19
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Validation of the geographic position of EPER-Spain industries
|International Journal of Health Geographics|2008|221